[Clinical evaluation of Duraphat and Fluor-Protector preparations in caries prevention].
D000293:Adolescent; D002648:Child; D003731:Dental Caries / Q000517:prevention & control*; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005460:Fluorides, Topical / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010150:Paint; D011140:Polyurethanes / Q000008:administration & dosage / Q000627:therapeutic use*; D012821:Silanes / Q000008:administration & dosage / Q000627:therapeutic use*; D012825:Silicon / Q000627:therapeutic use*; D012969:Sodium Fluoride / Q000008:administration & dosage / Q000627:therapeutic use*; D014070:Tooth / Q000033:anatomy & histology
D004338:Drug Combinations; D005460:Fluorides, Topical; D011140:Polyurethanes; D012821:Silanes; C023807:sodium fluoride topical preparation; C022599:Fluor Protector; D012969:Sodium Fluoride; D012825:Silicon
Ocena kliniczna preparatów Duraphat i Fluor-Protector w profilaktyce próchnicowej.